Edgewise Therapeutics News - EWTX

Company Name	Stock Ticker Symbol	Market	Type
Edgewise Therapeutics Inc	EWTX	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.46	2.94%	16.11	17:30:02

Open Price	Low Price	High Price	Close Price	Prev Close
15.65	15.60	16.33	16.11	15.65

more quote information »

Recent News

Date	Time	Source	Heading
4/23/2024	08:00	BW	Edgewise Receives European Medicines Agency (EMA) Orphan..
4/15/2024	16:05	BW	Edgewise Therapeutics Announces Positive Two-Year Topline..
3/28/2024	08:00	BW	Edgewise Therapeutics Announces Upcoming Podium Presentation..
3/27/2024	08:00	BW	Edgewise Therapeutics to Present at the Cantor Virtual..
3/05/2024	08:00	BW	Edgewise Therapeutics to Present at the Leerink Partners..
2/28/2024	08:00	BW	Edgewise Therapeutics to Present on EDG-5506 for the..
2/22/2024	08:07	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/22/2024	08:00	EDGAR2	Form 8-K - Current report
2/22/2024	08:00	BW	Edgewise Therapeutics Reports Fourth Quarter and Full Year..
2/14/2024	08:43	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	08:00	BW	Edgewise Receives U.S. FDA Fast Track Designation for..
2/09/2024	17:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/07/2024	16:15	EDGAR2	Form 144 - Report of proposed sale of securities
1/19/2024	16:54	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/19/2024	08:44	EDGAR2	Form 8-K - Current report
1/19/2024	08:37	BW	Edgewise Therapeutics Announces Pricing of $240 Million..
1/19/2024	06:05	EDGAR2	Form 8-K - Current report
1/19/2024	06:04	EDGAR2	Form S-3MEF - Registration adding securities to prior Form..
1/19/2024	06:02	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
1/09/2024	08:39	BW	Edgewise Therapeutics Highlights 2023 Accomplishments and..
12/28/2023	16:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	16:32	EDGAR2	Form 144 - Report of proposed sale of securities
12/19/2023	08:00	BW	Edgewise Therapeutics to Present at the 42nd Annual J.P...
12/18/2023	08:00	BW	Edgewise Therapeutics Launches First of Its Kind Educational..
11/30/2023	08:56	DJN	Edgewise Gets FDA Orphan, Rare-Pediatric-Disease..
11/30/2023	08:00	BW	Edgewise Receives Orphan Drug and Rare Pediatric Disease..
11/09/2023	08:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	08:00	EDGAR2	Form 8-K - Current report
11/09/2023	08:00	BW	Edgewise Therapeutics Reports Third Quarter 2023 Financial..
11/08/2023	08:00	BW	Edgewise Therapeutics to Present at Upcoming Investor..
11/01/2023	08:00	BW	Edgewise to Present Data on EDG-7500 at the American Heart..
10/26/2023	08:00	BW	Edgewise Therapeutics Announces Expansion of their EDG-5506..
9/27/2023	08:00	BW	Edgewise Therapeutics to Present on EDG-5506 for Becker..
9/26/2023	08:00	BW	Edgewise Therapeutics Announces Initiation of GRAND CANYON,..
9/14/2023	08:00	BW	Edgewise Therapeutics Begins Dosing First-in-Human Phase 1..
8/18/2023	19:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/18/2023	19:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/10/2023	08:01	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	08:00	EDGAR2	Form 8-K - Current report
8/10/2023	08:00	BW	Edgewise Therapeutics Reports Second Quarter 2023 Financial..
7/14/2023	16:05	EDGAR2	Form 8-K - Current report
6/26/2023	16:01	BW	Edgewise Therapeutics Announces Positive 12-Month Topline..
6/06/2023	08:00	BW	Edgewise Therapeutics to Present at the Goldman Sachs Global..
5/11/2023	08:00	BW	Edgewise Therapeutics Reports First Quarter 2023 Financial..
5/02/2023	08:00	BW	Edgewise Therapeutics to Present at Upcoming Investor..